Ovarian cancer surgery: does following guidelines save money and improve life quality?

NCT ID NCT02854215

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether following national guidelines for ovarian cancer surgery is cost-effective. Researchers measured the cost per quality-adjusted life year (QALY) over three years in 200 women with advanced ovarian cancer. The goal was to understand the economic impact of guideline adherence, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fallopian tube cancer ovarian cancer primary peritoneal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Hospitalier Lyon Sud 1

    Pierre-Bénite, 69495, France

  • Centre Hospitalier Lyon Sud 2

    Pierre-Bénite, 69495, France

  • Centre Jean Perrin

    Clermont-Ferrand, 63011, France

  • Chu Clermont Ferrand

    Clermont-Ferrand, 63003, France

  • Hopital Nord-Ouest - Villefranche Sur Saone

    Villefranche-sur-Saône, 69655, France

  • Institut Bergonie

    Bordeaux, 33076, France

  • Institut Claudius Regaud

    Toulouse, 31059, France

  • Institut Curie

    Paris, 75248, France

  • Institut Paoli Calmettes

    Marseille, France

  • Institut Regional Du Cancer Montpellier

    Montpellier, 34298, France